Dargaville, P. A. Et Al. 2021. Effect of Minimally Invasive Surfactant Therapy vs Sham Treatment on Death or Bronchopulmonary Dysplasia in Preterm Infants With Respiratory Distress Syndrome: The OPTIMIST-A Randomized Clinical Trial.. JAMA , vol.326 , 2478-2487.

Dargaville, P. A., Kamlin, C. O. F., Orsini, F., Wang, X., De Paoli, A. G., Kanmaz Kutman, H. G., ... Cetinkaya, M.(2021). Effect of Minimally Invasive Surfactant Therapy vs Sham Treatment on Death or Bronchopulmonary Dysplasia in Preterm Infants With Respiratory Distress Syndrome: The OPTIMIST-A Randomized Clinical Trial.. JAMA , vol.326, 2478-2487.

Dargaville, Peter Et Al. "Effect of Minimally Invasive Surfactant Therapy vs Sham Treatment on Death or Bronchopulmonary Dysplasia in Preterm Infants With Respiratory Distress Syndrome: The OPTIMIST-A Randomized Clinical Trial.," JAMA , vol.326, 2478-2487, 2021

Dargaville, Peter A. Et Al. "Effect of Minimally Invasive Surfactant Therapy vs Sham Treatment on Death or Bronchopulmonary Dysplasia in Preterm Infants With Respiratory Distress Syndrome: The OPTIMIST-A Randomized Clinical Trial.." JAMA , vol.326, pp.2478-2487, 2021

Dargaville, P. A. Et Al. (2021) . "Effect of Minimally Invasive Surfactant Therapy vs Sham Treatment on Death or Bronchopulmonary Dysplasia in Preterm Infants With Respiratory Distress Syndrome: The OPTIMIST-A Randomized Clinical Trial.." JAMA , vol.326, pp.2478-2487.

@article{article, author={Peter A Dargaville Et Al. }, title={Effect of Minimally Invasive Surfactant Therapy vs Sham Treatment on Death or Bronchopulmonary Dysplasia in Preterm Infants With Respiratory Distress Syndrome: The OPTIMIST-A Randomized Clinical Trial.}, journal={JAMA}, year=2021, pages={2478-2487} }